/
Burzynski Research Institute, Inc. (the Company ) was incorporated under the laws of the State of Delaware in 1984 in order to engage in the research, production, marketing, promotion and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids which are known under the trade name Antineoplastons. The Company believes Antineopla…
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
-$1M
▼ -3.8% YoY
Op. Margin
—
ROIC
—
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$258K
▲ +25.8% YoY
Net Debt
-$2K
Net Cash Position
Cash & Equiv.
$2K
Continue Research